CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

Regulations
May.14
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.

Key Points

  • U.S. seizes 18 million illegal vapes;
  • Operation targets China-origin shipments;
  • Products valued at over $175 million;
  • All seized products lacked FDA authorization.
  • Release date coincided with Trump’s Beijing arrival.

2Firsts

May 13, 2026

According to U.S. Customs and Border Protection (CBP), the agency, together with the U.S. Coast Guard and the Food and Drug Administration (FDA), seized more than 18 million e-cigarette products valued at over $175 million during “Operation Red Mist.”

CBP said the operation primarily targeted maritime vape cargo shipments originating from China and focused on combating the illicit importation, transportation, and distribution of vaping products and related hazardous components.

Authorities said the enforcement effort involved intelligence analysis, cargo targeting, and interagency coordination across multiple stages of the supply chain, including pre-shipment screening, port-of-entry inspections, and post-seizure investigations.

During the operation, investigators identified shipments involving hazardous material misclassification, improper labeling, and attempts to evade taxes, duties, and regulatory oversight.

CBP said some products also violated U.S. import requirements for tobacco products, transportation safety standards for electronic devices, and environmental protection regulations.

The FDA stated that all e-cigarette products seized during Operation Red Mist lacked FDA premarket authorization and therefore could not be legally marketed in the United States.

According to FDA data, only 41 vaping products are currently authorized for legal sale in the U.S.

Diane J. Sabatino, Executive Assistant Commissioner for CBP’s Office of Field Operations, said:

“The spread of illegal e-cigarettes is alarming for communities everywhere.”

She added that frontline officers are working to prevent such products from entering the market, particularly to keep them away from young consumers.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
Diane J. Sabatino, Executive Assistant Commissioner, Office of Field Operations, U.S. Customs and Border Protection (CBP).|Image source:CBP

CBP said the operation forms part of a broader federal crackdown on illegal vaping products aimed at preventing unsafe devices from reaching U.S. communities and retail shelves.

The agency also noted that revenue generated from counterfeit and noncompliant imports is often linked to broader criminal activities.

Public information shows CBP enforces more than 400 laws on behalf of over 40 federal agencies, with trade enforcement responsibilities covering import safety, intellectual property protection, and hazardous goods oversight.

Timing, Code Name and FDA Authorization Count

The announcement also contains several timing and wording details. CBP listed both the release date and the last-modified date as May 13, 2026. The release identified the initiative by its code name, “Operation Red Mist,” and stated: “Operation Red Mist primarily targets maritime cargo shipments originating from the People’s Republic of China and is designed to combat the illicit importation, transportation, and distribution of vapes and their hazardous components.”

CBP’s release also stated that “only 41 FDA-authorized products are permitted for U.S. marketing and distribution,” linking to FDA’s page for authorized e-cigarettes and other electronic nicotine delivery systems. FDA had announced on May 5, 2026, that it authorized four Glas ENDS products through the PMTA pathway. Including those products, the number of FDA-authorized e-cigarette products would be 45.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP’s May 13, 2026 release states that “only 41 FDA-authorized products” are permitted for U.S. marketing and distribution. | Image source: CBP

The discrepancy suggests that CBP’s May 13 release used an authorization count that did not reflect FDA’s May 5, 2026 authorization of four Glas ENDS products. One possibility is that CBP did not update the figure when drafting or publishing the release. Another is that the text had been written and cleared for publication before FDA authorized the Glas products on May 5, and was later published on May 13 without the authorization count being updated. CBP did not disclose when the release was drafted, approved or scheduled for publication.

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
FDA’s authorized e-cigarette product page states that 45 e-cigarettes are currently authorized by the agency. | Screenshot by 2Firsts on May 14, 2026, Beijing time; source: FDA

Follow 2Firsts for the latest updates on U.S. NGPs regulation and market developments.

(Cover Image source: CBP official news page)


2FIRSTS | FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
2FIRSTS | FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
www.2firsts.com

2FIRSTS | FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
2FIRSTS | FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
www.2firsts.com

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.
Jun.10
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13